$1.3 Billion is the total value of Eversept Partners, LP's 86 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AZN | ASTRAZENECA PLCcall | $37,966,382 | +13.9% | 572,300 | 0.0% | 2.92% | +36.9% | |
| MRK | MERCK & CO INCcall | $3,995,835 | +7.1% | 48,700 | 0.0% | 0.31% | +29.0% | |
| PGNY | PROGYNY INCput | $2,570,000 | +2.1% | 50,000 | 0.0% | 0.20% | +22.4% | |
| KRTX | KARUNA THERAPEUTICS INC | $2,020,272 | -3.2% | 15,934 | 0.0% | 0.16% | +16.5% | |
| MIST | MILESTONE PHARMACEUTICALS IN | $944,799 | -2.0% | 147,165 | 0.0% | 0.07% | +17.7% | |
| ENSG | ENSIGN GROUP INC | $936,406 | +7.2% | 10,397 | 0.0% | 0.07% | +28.6% | |
| CSU | SONIDA SENIOR LIVING INC | $503,874 | +16.3% | 15,209 | 0.0% | 0.04% | +39.3% | |
| ELDN | ELEDON PHARMACEUTICALS INC | $449,192 | -10.7% | 114,008 | 0.0% | 0.03% | +6.2% | |
| CYCN | CYCLERION THERAPEUTICS INC | $412,870 | -35.5% | 371,955 | 0.0% | 0.03% | -22.0% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $298,742 | -46.1% | 419,581 | 0.0% | 0.02% | -34.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.